Global Bio Similars Competitive Landscape Professional Research Report 2024

Global Bio Similars Competitive Landscape Professional Research Report 2024

Research Summary

Bio similars, also known as biosimilars or follow-on biologics, are pharmaceutical products that are highly similar to an already approved reference biological product (also known as the originator or reference product). These bio similars are developed to be highly similar in terms of quality, efficacy, and safety to the reference product. However, unlike generic versions of small-molecule drugs, which are identical copies of their reference products, bio similars are not exact replicas due to the complexity of biological molecules. Bio similars undergo a rigorous process of development and testing to demonstrate similarity to the reference product, ensuring that they are effective and safe for use. They are often used as more affordable alternatives to the reference product, providing increased access to important treatments and promoting competition in the biopharmaceutical market.

According to DIResearch's in-depth investigation and research, the global Bio Similars market size will reach XX US$ Million in 2024, and is expected to reach XX US$ Million in 2030, with a CAGR of XX% (2025-2030). Among them, the China market has changed rapidly in the past few years. The market size in 2024 will be XX US$ Million, accounting for approximately XX% of the world. It is expected to reach XX US$ Million in 2030, and the global share will reach XX%.

The major global manufacturers of Bio Similars include Sun Pharma, Synthon Pharmaceuticals, Teva Pharmaceutical Industries, LG Life Sciences, Celltrion Biocon, Hospira, Merck, Biogen idec, Genentech (Roche), Pfizer, Celltrion, Biocon, Amgen, Samsung Biologics, Mylan, Dr. Reddy＇s Laboratories, Stada Arzneimittel, AbbVie, Sanofi-Aventis, Johnson & Johnson, Novo Nordisk, Eli Lilly, Novartis, 3sbio, Biotech, Gelgen, Innovent, Dong Bao, Ganlee etc. The global players competition landscape in this report is divided into three tiers. The first tiers is the global leading enterprise, which occupies a major market share, is in a leading position in the industry, has strong competitiveness and influence, and has a large revenue scale; the second tiers has a certain share and popularity in the market, actively follows the industry leaders in product, service or technological innovation, and has a medium revenue scale; the third tiers has a smaller share in the market, has a lower brand awareness, mainly focuses on the local market, and has a relatively small revenue scale.

This report studies the market size, price trends and future development prospects of Bio Similars. Focus on analysing the market share, product portfolio, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Bio Similars market. The report data covers historical data from 2019 to 2023, base year in 2024 and forecast data from 2025 to 2030.

The regions and countries in the report include North America, Europe, China, APAC (excl. China), Latin America and Middle East and Africa, covering the Bio Similars market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Bio Similars industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.

The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.

Global Key Manufacturers of Bio Similars Include:

Sun Pharma

Synthon Pharmaceuticals

Teva Pharmaceutical Industries

LG Life Sciences

Celltrion Biocon

Hospira

Merck

Biogen idec

Genentech (Roche)

Pfizer

Celltrion

Biocon

Amgen

Samsung Biologics

Mylan

Dr. Reddy＇s Laboratories

Stada Arzneimittel

AbbVie

Sanofi-Aventis

Johnson & Johnson

Novo Nordisk

Eli Lilly

Novartis

3sbio

Biotech

Gelgen

Innovent

Dong Bao

Ganlee

Bio Similars Product Segment Include:

Monoclonal Antibodies

Interferon

Erythropoietin

Insulin

Vaccines

Other

Bio Similars Product Application Include:

Tumor

Diabetes

Cardiovascular

Hemophilia

Other

Chapter Scope

Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trends

Chapter 2: Global Bio Similars Industry PESTEL Analysis

Chapter 3: Global Bio Similars Industry Porter’s Five Forces Analysis

Chapter 4: Global Bio Similars Major Regional Market Size and Forecast Analysis

Chapter 5: Global Bio Similars Market Size and Forecast by Type and Application Analysis

Chapter 6: North America Bio Similars Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 7: Europe Bio Similars Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 8: China Bio Similars Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 9: APAC (Excl. China) Bio Similars Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 10: Latin America Bio Similars Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 11: Middle East and Africa Bio Similars Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 12: Global Bio Similars Competitive Analysis of Key Manufacturers (Revenue, Market Share, Regional Distribution and Industry Concentration)

Chapter 13: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)

Chapter 14: Industrial Chain Analysis, Include Raw Material Suppliers, Distributors and Customers

Chapter 15: Research Findings and Conclusion

Chapter 16: Methodology and Data Sources